Nationally ranked
U.S. News & World Report ranked our pediatric orthopaedic program among the nation’s best in 2020–2021, in collaboration with Shriners Hospitals for Children – Northern California, our longstanding partner on orthopedic disorders and spinal injuries.
Promising results in Duchenne clinical trial
Using stem cells derived from heart muscle cells, UC Davis researchers have found promising results for a potential treatment for people with Duchenne’s muscular dystrophy, a progressive genetic disorder that mostly affects boys. Craig McDonald, one of the world's leading experts on the disease and national principal investigator on the clinical trial HOPE-2, found that participants who recently completed the trial showed improvement in their heart and lung function and upper body strength.
